home > Past Meetings > ESCMID Conference on the Impact of Vaccines on Public Health

ESCMID Conference on the Impact of Vaccines on Public Health
1 - 3 April 2011, Prague, Czech Republic
Conference Objectives
As part of its multifaceted approach to infections, ESCMID strives to promote vaccination and worries that the current lack of correct information among both lay public and health care providers might seriously undermine the efficacy of current and future vaccine campaigns.
This conference will bring together world-leading experts to debate the many-sided correlations between vaccines, medicine and society at the dawn of the third millennium.
Supported by:
In cooperation with
Advanced Programme
1 and 2 April 2011
The Landscape
- The enduring threat of infectious diseases
- Measuring the impact of vaccines on the burden of disease in the population
Vaccines Facing the Problems of the XXI Century
- Vaccines and travellers
- Vaccines for disasters
- Vaccines, migration and geographical spread
- Vaccines boost the economies of poor countries
- Immunisations against bioterrorism: smallpox and anthrax
Vaccines for Special Patients
- Vaccines for the elderly
- HPV vaccination and primary prevention of cervical cancer
- Vaccination of immunocompromised patients
- Update on pertussis at the extremes of ages or in young children
- What are the priorities for incompletely vaccinated individuals?
Vaccines for Children
- The value of vaccines in pediatrics
- Neonatal meningitis: Group B streptococci
- Rotaviruses vaccination: a worldwide perspective
- Vaccines for mothers and children: maternal immunisation
Big Challenges and Unmet Needs
- Measles still spreads in Europe: who is responsible for the failure to vaccinate?
- Polio, between eradication and resurgence
- A vaccine for HIV
- Vaccines targeting nosocomial infections
- The malaria vaccine pipeline
Vaccinology, an Evolving Science
- How trust in immunisation can be built, nourished and maintained
- The vaccine production process: hi-tech development for modern vaccinology
- Vaccine administration routes and novel delivery technology
- Vaccine adjuvant as immunological drivers
- Vaccines at the human-animal interface (livestock/veterinary/aquaculture)
Influenza
- Pandemic flu and the anti-H1N1 vaccine, a retrospective view
- Compliance with anti-H1N1 vaccine among HCW and general population
- Children and flu
- Optimising flu recommendations: the European view
Vaccines, Media and Community
- Monitoring and assessing vaccine safety: a European perspective
- Harmonisation of vaccination policy across regions
- Opposition to vaccines and risks for public health
- Communicating risk in the media: bad science?
- Global safety of vaccines: strengthening systems for monitoring and management
- Value-based pricing for vaccines, a public health challenge?
- The key players: industry, researchers, governments and foundations
Pneumococcal Disease
- Understanding the burden of pneumococcal disease in adults
- Pneumococcal infection management in the antimicrobial-resistance era
- Pneumococcal vaccines for children: why recommend it?
- The role of pneumococcal vaccination in prevention of influenza-associated morbidity
Meningococcal Disease: Recent Developments and Novel Challenges
- International epidemiology of meningococcal disease and the unmet need for vaccines
- The pathogenesis of meningococcal disease and implications for vaccine development
- Impact of serogroup A, C, W135 and Y vaccines and the influence of formulation and boosting
- Recent data from clinical trials of novel serogroup B vaccines
- Latest meningococcal vaccination recommendations across regions
3 April 2011
The History of Vaccination - 4th International Day for Fighting Infection
- A world without vaccines
- Vaccination in the ancient Chinese Medicine
- From Jenner to smallpox eradication
- Louis Pasteur
- The history of pneumococcal vaccination
- Global eradication of poliomyelitis
- Maurice Hilleman
- Haemophilus influenzae and its prevention by vaccine
- HBV and recombinant vaccines
- Reverse vaccinology: developing vaccines in the era of genomics
Target Audience
Specialists or physicians in training in the following disciplines: infectious diseases, clinical microbiology, hygiene, public health, vaccinology and other disciplines dealing with all aspects of vaccination
Registration Procedure
Please download the registration form (see link on the right) and return it to the course administrative secretariat.
Registration Fee
Members of ESCMID and Affiliated Societies
- Before and on 8 January 2011: EUR 500
- After 8 January 2011: EUR 600
All others
- Before and on 8 January 2011: EUR 700
- After 8 January 2011: EUR 800
The registration fee includes the scientific sessions, printed conference material, lunches and coffee breaks, but not travel and accommodation costs.
Attendance Grants
ESCMID provides a number of attendance grants for young attendees (40 years or younger) covering the registration fee, but no travel or accommodation costs. Please submit your application until 21 February 2011 online on this website (follow the link on the right). If there are more applicants than available grants, preference will be given to ESCMID members. Applicants will be informed about their acceptance by 7 March 2011.
Please note that attendance grant application does not include registration for the Conference. Please register separately with the form supplied on the right.
Scientific Secretariat
Giuseppe Cornaglia
Dept. of Pathology and Diagnostics
University of Verona
Strada Le Grazie 8
37134 Verona
Italy
Phone + 39 045 802 7196
Fax + 39 045 802 7101
Conference Secretariat
ICO
Marco Moschin
Via Lorenzo Marcello 32
30126 Lido di Venezia (VE)
Italy
Phone +39 041 52 62 530
Friday, 1 April 2011
|
The Current Landscape |
|
|---|---|
|
08:00 |
The role of the WHO-Europe. Zsuzsanna Jakab, Director |
|
08.30 |
The role of the ECDC. Marc Sprenger, Director |
|
09.00 |
The enduring threat of infectious diseases. Alasdair Geddes |
|
09.30 |
Measuring the impact of vaccines on the burden of disease in the population. Kathryn M. Edwards |
|
Vaccines for Children |
|
|---|---|
|
10:30 |
The Value of vaccines in paediatrics. Fred Zepp |
|
11.00 |
Rotaviruses vaccination: a worldwide perspective. Timo Vesikari |
|
11.30 |
Neonatal meningitis: Group B strep. Paul Heath |
|
12.00 |
Vaccines for mothers and children: maternal immunization. Susanna Esposito |
|
Vaccines Facing the Problems of the XXI Century |
|
|---|---|
|
13:30 |
Vaccines and vaccine-preventable diseases in international travellers. Philippe Grautret |
|
14:00 |
Vaccination and natural disasters. Michel Van Herp |
|
14.30 |
Vaccines boost the economies of poor countries. David Bloom |
|
15.00 |
Immunisations against bioterrorism: smallpox and anthrax. Wendy Keitel |
|
Pneumococcal Disease |
|
|---|---|
|
16:00 |
Understanding the burden of pneumococcal disease in adults. Francesco Blasi |
|
16:30 |
Pneumococcal infection management in the AR era . Tobias Welte |
|
17:00 |
Pneumococcal vaccines for children: why to recommend it? Klara Posfay-Barbe |
|
17:30 |
The role of pneumococcal vaccination in prevention of influenza-associated morbidity. Keith Klugman |
Saturday, 2 April 2011
|
Vaccines for Special Patients |
|
|---|---|
|
08.30 |
Vaccines for the elderly. Birgit Weinberger |
|
09.00 |
HPV vaccination and primary prevention of cervical cancer. Mario Poljak |
|
09.30 |
Vaccination of immunocompromised patients. Per Ljungman |
|
10.00 |
Update on pertussis at the extremes of ages. Kathryn M. Edwards |
|
Influenza |
|
|---|---|
|
11.00 |
Pandemic flu and the anti-H1N1 vaccine, a retrospective view. Albert Osterhaus |
|
11.30 |
Compliance with anti-H1N1 vaccine among HCW and general population. Francesco Blasi |
|
12.00 |
Children and flu. Susanna Esposito |
|
12.30 |
Optimising flu recommendations: the European view. Angus Nicoll |
|
Vaccines, Media and Community |
|
|---|---|
|
14:00 |
Global safety of vaccines: strengthening systems for monitoring and management. Hanna Nohynek |
|
14:30 |
Monitoring and assessing vaccine safety: a European perspective. Johan Giesecke |
|
15:00 |
Harmonisation of Vaccination policy across region. Pierluigi Lopalco |
|
15.30 |
Value-based pricing for vaccines, a public health challenge? David Bloom |
|
Meningococcal Disease: Recent Developments and Novel Challenges |
|
|---|---|
|
16:30 |
International epidemiology of meningococcal disease and the unmet need for vaccines. Pavla Krizova |
|
17.00 |
The pathogenesis of meningococcal disease and implications for vaccine development. Richard Moxon |
|
17.30 |
Impact of Serogroup A, C, W135 and Y vaccines and the influence of formulation and boosting. Jamie Findlow |
|
18.00 |
Recent data from clinical trials of novel serogroup B vaccines. Matthew Snape |
Sunday, 3 April 2011
|
The History of Vaccination - 4th International Day for Fighting Infection |
|
|---|---|
|
08.30 |
Immunisation in the ancient Chinese medicine. Po-Ren Hsueh |
|
09.00 |
From Jenner to smallpox eradication. Alasdair Geddes |
|
09.30 |
Louis Pasteur. Patrick Berché |
|
10.00 |
Vaccines to prevent Haemophilus influenzae type b diseases. Richard Moxon |
|
11:00 |
The history of pneumococcal vaccination. Keith Klugman |
|
11.30 |
Global eradication of poliomyelitis. Donato Greco |
|
12.00 |
Maurice Hilleman and the MMR vaccine. Barbara Kuter |
|
12.30 |
Reverse vaccinology: developing vaccines in the era of genomics. Rino Rappuoli |
|
Big Challenges and Unmet Needs |
|
|---|---|
|
14:00 |
Measles still spreads in Europe: who is responsible for the failure to vaccinate? Pierluigi Lopalco |
|
14.30 |
Polio, between eradication and resurgence. Donato Greco |
|
15.00 |
A vaccine for HIV. Barbara Ensoli |
|
15.30 |
The malaria vaccine pipeline. Joe Cohen |
|
Vaccinology, an Evolving Science |
|
|---|---|
|
16.30 |
The vaccine production process: Hi-Tech development for modern Vaccinology. Rino Rappuoli |
|
17.00 |
Vaccine administration routes and novel delivery technology. Fabienne Anjuère |
|
17.30 |
Vaccine adjuvant as immunological drivers. Giuseppe Del Giudice |
檔案類型:
xls
pdf
doc
ppt
其他格式檔
| 編號 | 名稱 | 上傳日期 | 下載 | 簡介 |



Home 








